BioNeutral Ygiene Kills Swine Flu in 20 Seconds, Test Shows
BioNeutral of Newark, NJ, announced that its Ygiene Consumer Grade antimicrobial formulation swiftly eradicated the H1N1 swine flu virus in an independent lab test.
feature2
Power3 Medical Files for 3 Patents for Breast Cancer Test
Power3 Medical Products, a company specializing in disease detection through the analysis of proteins, has filed for three patents on its blood test for the early detection of breast cancer.
MediciNova to Buy Avigen for $37 Million
Pharmaceutical company MediciNova announced that it will buy Avigen (AVGN) for $1.24 per share, approximately $37 million.
SyntheMed REPEL-CV Receives Russian Approval
SyntheMed announced that its REPEL-CV barrier has received approval from the Ministry of Health of the Russian Federation for use in all patients who undergo open heart surgery.
Sirtris Begins Clinical Trials On Anti-Aging Drug
The New York Times reports that at least one company has taken a large step in its quest to extend the human lifespan.
Jennerex Raises $5.1 Million for Oncology Pipeline
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.
FDA Approves Harder-to-Abuse Painkiller Embeda
King Pharmaceuticals announced that the painkiller Embeda has been approved by the U.S. Food and Drug Administration for the management of moderate to severe chronic pain.
Anadys Shares Jump Following Hepatitis C Drug Trial
Shares in Anadys Pharmaceuticals rose 28 percent following the announcement of promising results in a clinical trial of its experimental hepatitis C drug ANA773.
Dendreon to Build $70 Million Plant Near Atlanta
The 160,000 square-foot facility could bring at least 300 jobs to Georgia.
New Software Brings Scientists Together
Imagine thousands of scientists across the globe collaborating to find a cure for cancer, or create a new malaria vaccine.